Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma

Glioblastoma multiforme (GBM), a fatal brain tumour with no available targeted therapies, has a poor prognosis. At present, radiotherapy is one of the main methods to treat glioma, but it leads to an obvious increase in inflammatory factors in the tumour microenvironment, especially IL‐6 and CXCL1, ...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guanzheng, Li, Huan, Zhang, Wanhong, Yu, Jiefeng, Zhang, Xu, Wu, Runqiu, Niu, Mingshan, Liu, Xuejiao, Yu, Rutong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335695/
https://www.ncbi.nlm.nih.gov/pubmed/34216174
http://dx.doi.org/10.1111/jcmm.16767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335695/
https://www.ncbi.nlm.nih.gov/pubmed/34216174
http://dx.doi.org/10.1111/jcmm.16767

Ejemplares similares